Symbols

RNAM

Avidity Biosciences·NASDAQ

--(--)

Is RNAM fundamentally strong?

RNAM scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its -43.98% ROE, -3650.39% net margin, -16.50 P/E ratio, 6.69 P/B ratio, and -71.97% earnings growth, these metrics solidify its Neutral investment rating.